Move to acceptance of qualified overseas drug evaluations, rather than repeat testing in New Zealand
Support the independence of Pharmac
Ensure cost/benefit analyses take into account the full economic cost of ill health, such as unemployment and inability to do unpaid work, when assessing the costs and benefits of a drug.
Ban the ‘direct to consumer’ advertising of pharmaceuticals, because this practice drives up the demand for pharmaceuticals and plays down adverse reactions to drugs
Require every pharmaceutical sold in NZ to contain a consumer information panel, which explains the risks and potential adverse reactions to that product clearly and comprehensively.
Place tighter controls on the routine prescription of highly addictive drugs, and educate doctors, patients, and the public about the risks of dependence and use of safe alternatives
National will boost funding to Pharmac by $75 million over the next three years
National will undertake a review of New Zealand’s pharmaceutical policy to consider the trade-offs between pharmaceutical and other forms of treatment, and to explore options for providing patients with a greater choice of drugs
Extend free doctors visits and prescriptions to include all primary school-aged children
Conduct a review of the efficiency and efficacy of Pharmac's operations
Review the use and availability of methadone with the intention of reducing methadone reliance
Review the role and operations of Pharmac to ensure that not only are pharmaceuticals made available at the most competitive price, but also that the interests of individual patients are taken into account when funding decisions are made
Develop a national medicines strategy to ensure quality use of pharmaceuticals, and to ensure that New Zealanders have access to the most up to date drugs